Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; NIDA-L Medications Development Conflicts, Special Emphasis Panel.
Date: February 12, 2009.
Time: 2:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: Double Tree Hotel, 1515 Rhode Island, NW., Washington, DC 20005.
Contact Person: Scott Chen, Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6101 Executive Boulevard, Room 220, MSC 8401, Bethesda, MD 20892, 301-402-6020, firstname.lastname@example.org.
(Catalogue of Federal Domestic Assistance Program Nos. 93279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS)Start Signature
Dated: January 9, 2009.
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-995 Filed 1-21-09; 8:45 am]
BILLING CODE 4140-01-M